Crossmark

ASO Author Reflections: Objective Response Rate after Short Duration (< 9 Weeks) Is Not Inferior to Moderate (9–27 Weeks) or Long Duration (> 27 Weeks) of Neoadjuvant Endocrine Therapy (NET)—An NCDB Analysis

Crossref DOI link: https://doi.org/10.1245/s10434-021-10517-w

Published Online: 2021-07-24

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Burkbauer, Laura

Goldbach, Macy M. https://orcid.org/0000-0002-9986-1139
Tchou, Julia C.
License Information

Text and Data Mining valid from 2021-07-24

Version of Record valid from 2021-07-24
More Information

Article History

Received: 13 July 2021

Accepted: 14 July 2021

First Online: 24 July 2021

Disclosures

: The authors report no relevant commercial or financial disclosures.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below